Beyond sudden death prevention: Minimizing implantable cardioverter defibrillator shocks and morbidity and optimizing efficacy

Michael Glikson, David Luria, Osnat Gurevitz, Paul A. Friedman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Implantable cardioverter Defibrillator shocks are the most effective way to immediately terminate life-threatening ventricular arrhythmias. Failed ICD shocks are rare with modern Defibrillators. Large database analysis reveals that less than 2% of appropriate ICD therapies fail to terminate ventricular tachycardia or ventricular fibrillation (VT/VF) episodes.1 Even among ICD recipients who die suddenly, device interrogation demonstrates ineffective shocks as the cause of death in only a minority of cases.2,3

Original languageEnglish (US)
Title of host publicationElectrical Diseases of the Heart
Subtitle of host publicationGenetics, Mechanisms, Treatment, Prevention
PublisherSpringer London
Pages781-800
Number of pages20
ISBN (Print)9781846288531
DOIs
StatePublished - Dec 1 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Beyond sudden death prevention: Minimizing implantable cardioverter defibrillator shocks and morbidity and optimizing efficacy'. Together they form a unique fingerprint.

  • Cite this

    Glikson, M., Luria, D., Gurevitz, O., & Friedman, P. A. (2008). Beyond sudden death prevention: Minimizing implantable cardioverter defibrillator shocks and morbidity and optimizing efficacy. In Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention (pp. 781-800). Springer London. https://doi.org/10.1007/978-1-84628-854-8_56